Dhargam Aljebouri/LinkedIn
Sep 28, 2026, 19:07
Dhargam Aljebouri: AIHA Subclassification Research Presented at the 14th Iraqi Society of Hematology Conference
Dhargam Aljebouri, Laboratory Director at Clinical Immunology, Allergy and Transfusion Medicine – Specialized Immunosciences Laboratory, shared a post on LinkedIn:
“Glad to have presented my work on Autoimmune Hemolytic Anemia (AIHA) subclassification through comprehensive immunohematological profiling at the 14th Annual Scientific Conference of the Iraqi Society of Hematology, held in Baghdad, Iraq, on 24–25 September 2026.”
Stay updated with Hemostasis Today.
-
Nov 8, 2026, 14:55Andra T.: Antiphospholipid Syndrome and Its Thrombotic Risks
-
Nov 8, 2026, 14:06Shayan Mohammadmoradi: ZEUS Trial-Inflammation Reduction Without Fewer Cardiovascular Events
-
Nov 8, 2026, 14:05Kausik Ray: Plaque-Guided Care for Better Coronary Outcomes
-
Nov 8, 2026, 14:05Athira Elssa Johnson: Understanding Coronary Thrombosis and Its Risks
-
Nov 8, 2026, 14:04Sanjiv Beri: Blood Type Compatibility and the Balance of Giving and Receiving
-
Nov 8, 2026, 14:02Gabriela Hobbs: Recognizing Outstanding Abstract Achievements-ASH 2026
-
Nov 8, 2026, 12:22Marc Carrier: Advancing Catheter-Related Thrombosis Prevention Through Factor XI Inhibition
-
Nov 8, 2026, 11:56Why Genetic Predisposition Does Not Always Lead to Thrombosis – Stork Genetics
-
Nov 8, 2026, 11:45Sher-Lu Pai: Investigating Intracardiac Thrombosis and Its Management in Liver Transplantation